Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: Data from two randomized phase III trials

Robert J. Van Soest, A. J. Templeton, F. E. Vera-Badillo, F. Mercier, G. Sonpavde, E. Amir, B. Tombal, M. Rosenthal, M. A. Eisenberger, I. F. Tannock, R. DeWit

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: Data from two randomized phase III trials'. Together they form a unique fingerprint.

Medicine & Life Sciences